Use of Intravenous Vernakalant for Atrial Fibrillation Conversion in the Regular Ward Under Only Bedside Monitoring.

Use of Intravenous Vernakalant for Atrial Fibrillation Conversion in the Regular Ward Under Only Bedside Monitoring. Hellenic J Cardiol. 2018 Feb 15;: Authors: Manolis AS, Bethanis S, Metaxa S, Polytarchou K, Sakellaris N, Pyrros I PMID: 29454598 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29454598?dopt=Abstract

Source: Hellenic Journal of Cardiology - February 20, 2018 Category: Cardiology Tags: Hellenic J Cardiol Source Type: research

More News: Atrial Fibrillation | Cardiology | Heart